source
- Sanofi and Regeneron deepen collaboration, adding new immunology antibody programSanofi and Regeneron announced an expanded partnership that builds on the success of their joint drug Dupixet, targeting a pipeline of experimental antibodies for immunological disorders. Under th…
- HHS unveils ARPA-H SURPASS program to accelerate clinical trial designOn Oct 1, 2026 the U.S. Department of Health and Human Services announced a new initiative under the Advanced Research Projects Agency for Health. The initiative, named the Simulation-augmented, R…